Pharma Stock Roundup: MRK, LLY, ABBV Post Q4 Earnings, PFE Ends Vupanorsen Program

Published on February 4, 2022

AbbVie (ABBV), Merck (MRK), Eli Lilly (LLY) and Novartis (NVS) report fourth-quarter results. Pfizer (PFE) ends vupanorsen development.

Continue reading on website
Other news

Coronavirus Stimulus Check For The Deceased: Yes, The Dead Can Get A $1,400 Check

February 4, 2022
It’s been almost 11 months since Congress approved the third stimulus check of $1,400. More stimulus checks are highly unlikely, so it is important for you to claim all the...

U.S. Adds More Than 400,000 New Jobs in January, Shattering Expectations

February 4, 2022
The number is more than three times what many economists were forecasting.